Gold nanorod light scattering labels for biomedical imaging by Qiu, Le et al.
Gold nanorod light scattering labels for 
biomedical imaging 
Le Qiu,
1 Timothy A. Larson,
2 Edward Vitkin,
1 Lianyu Guo,
1 Eugene B. Hanlon,
1,3  
Irving Itzkan,
1 Konstantin V. Sokolov,
2,4 and Lev T. Perelman
1,* 
1Biomedical Imaging and Spectroscopy Laboratory, Beth Israel Deaconess Medical Center,  
Harvard University, Boston, Massachusetts 02215, USA 
2Departments of Biomedical Engineering and Chemical Engineering,  
University of Texas at Austin, Austin, Texas 78712, USA 
3Medical Research Service and Geriatric Research Education and Clinical Center,  
Department of Veterans Affairs, Bedford, Massachusetts 01730, USA 
4Departments of Biomedical Engineering and Imaging Physics, 
The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA 
*ltperel@bidmc.harvard.edu 
Abstract:  Gold  nanorods  can  be  used  as  extremely  bright  labels  for 
differential  light  scattering  measurements  using  two  closely  spaced 
wavelengths, thereby detecting human disease through several centimeters 
of tissue in vivo. They have excellent biocompatibility, are non-toxic, and 
are  not  susceptible  to  photobleaching.  They  have  narrow,  easily  tunable 
plasmon  spectral  lines  and  thus  can  image  multiple  molecular  targets 
simultaneously.  Because  of  their  small  size,  gold  nanorods  can  be 
transported to various tissues inside the human body via the vasculature and 
microvasculature, and since they are smaller than vascular pore sizes, they 
can easily cross vascular space and enter individual cells. 
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There  are  two  problems  in  visualizing  tumors  in  deep  tissue,  lack  of  contrast  and  tissue 
turbidity. In this paper we discuss the potential of gold nanorods to overcome these problems. 
They can serve as extremely bright light scattering labels for the detection of disease through 
several centimeters of tissue in humans in vivo. There is a common misconception, based on 
the high background signal associated with light absorption and scattering measurements, that 
absorption  and  scattering  probes  should  always  perform  poorly  compared  to  fluorescence 
probes such as quantum dots and molecular fluorophores. This is because the absorption and 
scattering labels are detected at the same wavelength as the excitation wavelength and are 
seen against a high background of light coming directly from the source. However, in the case 
of gold nanorods, this problem is overcome by two unusual properties of the nanoparticles. 
The first is their narrow absorption and scattering plasmon resonant linewidths [1,2]. It allows 
one  to  perform  differential  absorption  and  scattering  measurements  at  two  closely  spaced 
wavelengths. This effectively eliminates the background signal, although the noise associated 
with the subtracted background signal will still be present in the measurement. The second is 
their extremely high absorption and scattering plasmon resonant cross sections. These very 
large narrowband cross sections more than compensate for the effect of the noise associated 
with the subtracted background signal. 
At the same time gold nanorods have excellent biocompatibility, are not toxic [3], and are 
not susceptible to photobleaching. Their narrow and easily tunable plasmon spectral lines can 
thus  be  used  to  image  multiple  molecular  targets  simultaneously  [1].  Finally,  because, 
nanorod labels are smaller than vascular pore sizes, they can easily cross the vascular space to 
be delivered to various tissues and individual cells inside the human body via the vasculature 
and  microvasculature.  (Nanorod  labels  are  10-12  nm  diameter  and  25-50  nm  length  or 
approximately 3 to 5 times smaller than available quantum dots). 
Some  of  the  material  described  in  sections  2  and  3  has  been  previously  published 
elsewhere. We include it here for the convenience of the readers of this journal who may not 
be familiar with the nanorod literature. 
2. Theory of the optical properties of gold nanorods 
Nanoparticles with sizes small compared to the wavelength of light, made from metals with an 
appropriate  complex  index  of  refraction,  such  as  gold  and  silver,  have  absorption  and 
scattering resonance lines in the visible part of the spectrum. These lines are due to the in-
phase oscillation of free electrons and are called surface plasmon resonances. 
Since nanorods have spectra very similar to nanospheroids with the same aspect ratio, the 
absorption and scattering cross sections of gold nanospheroids are used to describe the optical 
properties of gold nanorods [4,5]. A rigorous solution for nonspherical particles, which can be 
considered an extension of Mie theory, was developed by Waterman and is called the T-
matrix approach [6]. For spherical particles the T-matrix approach becomes identical to Mie 
theory. Although this solution is exact it is not transparent. For particles much smaller than a 
wavelength, only the dipole term contributes significantly to the absorption cross-section [7], 
and thus a great deal of physical insight can be gained from conclusions drawn by examining 
the dipole approximation [2]. 
In  the  dipole  approximation  the  angle  averaged  absorption  cross-section  for  a 
nanospheroid is given by [8,9] 
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and the angle averaged scattering cross-section is 
#129107 - $15.00 USD Received 27 May 2010; revised 3 Jul 2010; accepted 6 Jul 2010; published 15 Jul 2010
(C) 2010 OSA 2 August 2010 / Vol. 1,  No. 1 / BIOMEDICAL OPTICS EXPRESS  136  ( )
2 2 ( ) 2 3 2
1 2 2
4 2 ( )
2
1 2 ( )
( ) /( ) 8
.
9 1
i
m m
sca
i i
m i
n
V
n
n
ε ε ε π ε
σ
λ
ε ε ε
− +
≅
  −
+ +  
 
∑   (2) 
Here ( ) ( ) ( )
2 2
1 n ε λ λ κ λ = − , ( ) ( ) ( ) 2 2n ε λ λ κ λ =  and
2
m m n ε =  where  ( ) n λ  and  ( ) κ λ  
are  the  real  and  imaginary  parts  of  the  complex  refractive  index  of  the  nanospheroid’s 
material,  m n  is the refractive index of the surrounding medium, and 
( ) i n  is the depolarization 
factor in the i-th direction [10]. 
The explicit dependence of the cross-sections on the aspect ratio, α, which is the ratio of 
the  length  to  the  diameter  of  the  nanoparticles  can  be  derived  using  two  simple 
approximations for the depolarization factor [2], yielding a good small α approximation of 
( ) 1/3
a n α ≅ . Using this approximation, for the range of aspect ratios from 1 to 4, Eq. (1) can 
be simplified 
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represents the transverse plasmon optical mode. We see that the red shift of the longitudinal 
mode  ( ) ( ) 1 3 1 m ε λ α ε = − −  is sensitive to the aspect ratio, varying almost linearly with it, and 
the position of the peak of the transverse mode  ( ) 1
2
1
3 1
m ε λ ε
α
  = − +   −  
 is insensitive to the 
aspect ratio, shifting only slightly from the position of the well known nanosphere plasmon 
spectral peak  ( ) 1 m ε λ ε ≅ − . In addition the plasmon transverse mode is heavily damped by the 
coefficient 
( )
2
8
3 1 α −
. This coefficient is less than 7% of the main peak at α = 4. 
While  the  scattering  and  absorption  cross-sections  exhibits  similar  behavior  for 
longitudinal and transverse plasmon modes [1,2], the scattering cross-section has a stronger 
wavelength dependence than the absorption cross-section. Indeed, the ratio of the scattering to 
absorption cross-sections is approximately proportional to 
( ) ( )
( ) ( )
2 2 2
2
m n
n
κ λ
λ κ λ
+
 [1]. This ratio is 
10 times greater at 700 nm than at 520 nm and explains why the transverse mode is barely 
seen in the scattering cross-section. (See Fig. 1 where we compare T-matrix calculations of 
normalized absorption and scattering cross-sections for several aspect ratios and diameters of 
nanospheroids. Here, the transverse mode for scattering disappears.) 
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Fig.  1.  Normalized  absorption  and  scattering  cross  sections  for  three  aspect  ratios,  α  and 
diameters d of nanospheroids modeled using the T-matrix approach [11]. The solid curves are 
for scattering while the dotted lines are for absorption. From left to right: α = 2.18 and d = 10 
nm, α = 3.2 and d = 10 nm, and α = 4.0 and d = 10 nm. Inset magnifies the curves in the 
vicinity of the 520 nm transverse mode. 
Our approximation agrees with the well known result of the dipole model that the spectral 
properties of nanospheroids depend only on the complex permittivity of the material and their 
aspect ratio but not size. Size enters only as a coefficient, changing the overall value of the 
cross-sections. Thus to tune the absorption and scattering lines of gold nanorods we should 
control for aspect ratio. Note however, that though the aspect ratio is the main factor deciding 
the position of the plasmon  spectral peak, it is shifted slightly  with other factors such as 
diameter and end geometry when non-dipole terms are taken into account [12]. 
3. Optical spectroscopy of single gold nanorods 
Samples containing a large number of gold nanorods usually exhibit relatively broad spectral 
lines. This broadened linewidth limits the use of nanorods with uncontrolled aspect ratios as 
effective molecular labels, since it would be rather difficult to image several types of nanorod 
markers simultaneously. 
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Fig. 2. Schematic of the single gold nanorod experiment using the CLASS system. 
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Fig. 3. Normalized scattering spectrum for a single gold nanorod. Dots: CLASS measurements. 
Other lines are T-matrix calculations for a nanorod with an aspect ratio of 3.25 and a diameter 
of 16.2 nm and various A values. Solid line is for the natural linewidth, A = 0. Also included 
are lines for A = 0.5 and A = 1. The curve for A = 0.13 is the best fit for measurements made 
on eight different nanorods. 
However, the calculated linewidth of a single gold nanorod is narrow. To confirm this we 
measured the linewidth of single gold nanorods using the CLASS microscope (see Fig. 2) we 
developed [13]. The experimental data from one of these measurments is shown in Fig. 3. The 
measured CLASS spectra were compared with numerical calculations which use the complex 
refractive index of gold and various values of the A-parameter, a phenomenological correction 
introduced in the literature to account for homogeneous broadening caused by finite size and 
interface effects. The curve for A = 0.13 is the best fit for measurements  made on eight 
different nanorods. This agrees very well with an A-parameter calculation using a quantum 
mechanical jellium model [14]. 
 
Fig. 4. Optical properties of an ensemble of gold nanorods. (a) TEM image of a sample of gold 
nanorods with an average length and standard deviation of 48.9 ± 5.0 nm and an average 
diameter and standard deviation of 16.4 ± 2.1 nm. (b) Experimentally measured extinction of 
the same sample of gold nanorods as in the TEM image in aqueous solution (blue dots) vs. T-
matrix  calculation  for  a  single  nanorod  with  length  and  diameter  of  48.9  and  16.4  nm 
respectively (red solid line). (c)  Aspect ratio distribution of gold nanorods as in the TEM 
image. (d) Ensemble spectrum calculated using aspect ratio distribution demonstrates good 
agreement with experimentally measured extinction of the sample of gold nanorods in aqueous 
solution. 
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exhibit  a  scattering  line  significantly  narrower  than  the  lines  routinely  observed  in 
experiments that involve multiple nanorods. These experiments also suggest that the observed 
broad  spectra  of  nanorod  samples  containing  large  number  of  nanoparticles  could  be 
explained by the inhomogeneous line broadening caused by the contribution of nanorods with 
various aspect ratios (see Fig. 4). Indeed, since the position of a nanorod spectral peak is very 
sensitive to its aspect ratio, we can demonstrate [1] that the ensemble spectrum calculated 
using aspect ratio distribution extracted from the TEM image of a sample of gold nanorods 
exhibits good agreement with the experimentally measured extinction of the same sample. 
A possible technique for obtaining a narrow aspect ratio distribution might employ devices 
already  developed  for  cell  sorting.  These  would  use  the  position  of  the  narrow  plasmon 
spectral line for particle discrimination. Narrow, easily tunable spectra might allow several 
biochemical species to be imaged simultaneously with molecular markers which employ gold 
nanorods of several different, controlled, aspect ratios as labels. These markers could be used 
for cellular microscopic imaging where even a single nanorod can be detected. Minimizing 
the  number  of  nanoparticles  should  reduce  possible  damage  to  a  living  cell.  For  optical 
imaging of tumors, multiple gold nanorods with a narrow aspect ratio distribution might be 
used. 
Thus we conclude that nanorod-based molecular markers selected for a narrow aspect ratio 
and, to a lesser degree, size distribution, could provide spectral lines sufficiently narrow for 
effective biomedical imaging. 
4. Comparison of the gold nanorod labels vs. fluorescent labels 
To evaluate the sensitivity of the gold nanorod label vs. various fluorescence dye and quantum 
dots labels, we performed numerical experiments modeling the propagation of light through 
slabs  of  turbid  tissues  of  various  thicknesses  (from  0.25 cm  to  7  cm).  Light  is  delivered 
through a 1 mm fiber bundle and collected with a detector of the same size. The collection 
time was 1 sec. The power of the illumination light was 100 mW, which is well below the 
maximum permissible exposure (MPE) level of 440 mW set by American National Standard 
Institute [15]. However, since nanorods are strong absorbers of light, they can raise local 
tissue  temperature.  Thus,  we  estimated  the  temperature  increase  in  tissue  for  proposed 
nanorod labels. The characteristic size of the region around an individual nanorod which will 
be heated in t = 1 second is  4 700 r kt c m ρ   ≅ ≈  where k is heat diffusion coefficient, ρ is 
tissue density, and c is tissue heat capacity. Since this size is significantly larger than the 
average distance between nanorods (10 µm), the temperature increase in tissue will be limited 
by  ( ) ( ) T N P t cV σ ρ   ≤ ⋅ ⋅ ⋅  where N is concentration of nanorods and P is power of the 
incoming light. For our nanorods, near the surface of the tissue where P is the highest, we get 
∆T ≈0.01°C, which poses no danger to the tissue. 
 
Fig. 5. Geometry and typical wavelength pair of the numerical simulation used to evaluate the 
sensitivity of various optical labels. 
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that  in  addition  to  the  probes  inside  the  tumor  we  will  have  probes  distributed  in  the 
surrounding tissue and used various contrast ratios from 0 (no probes outside the tumor) to 
0.1.  Concentration  of  the  probes  in  tissue  varied  from  102  to  1014  probes  per  cubic 
centimeter. 
To evaluate the ability to detect the “tumor” we calculated the signal to noise ratio (S/N) 
which is the ratio of the measured signal to the overall measured noise: 
 
2
0
.
T
d r
qF t S
N qF t N t N
=
+ +
  (4) 
where  q  is  quantum  efficiency  of  the  detector,  FT  is  the  tumor-related  photon  flux 
(photons/spot/second), F0 is the total photon flux which is the sum of FT and background flux, 
t is the integration time per spot, Nd is dark current of the detector (electrons/spot/sec), and Nr 
is the read noise (electrons RMS/spot). To minimize the effect of the detector we have chosen 
characteristics  of  a  standard  available  high-end  CCD  camera:  q  =  0.5,  Nd  =  0.01 
electrons/spot/sec Nr = 10 electrons RMS/spot. 
In the case of fluorescent dyes and quantum dots FT≈F0, and in the case of scattering 
probes FT << F0, which significantly reduces, as we already discussed above, the efficiency of 
the scattering probes. However, to evaluate the overall effect of the increased background vs. 
increased cross section for the gold nanorod probes we need to perform accurate modeling. 
The  results  of  this  modeling  are  presented  in  Fig.  6.  To  compare  various  labels  (ICG, 
Rhodamine 6G, DDI and NIR1 fluorescence dyes, CdTe/CdS and CdTe/ZdS quantum dots, 
11 nm diameter, 3.3 aspect ratio and 10 nm diameter, 4.0 aspect ratio gold nanorods) we 
calculated concentration of labels (per mm
3) needed to achieve S/N = 10 which we consider to 
be minimum detectable level (Fig. 6a). As we can see the concentration of gold nanorod label 
(red curves) is three orders of magnitude lower than that of NIR1 fluorescence dye (green 
curve) and CdTe/CdS quantum dot (blue curve). In the vicinity of 5 cm tissue slab, which can 
be  considered  a  realistic  thickness  of  a  breast  during  mammographic  imaging,  the 
concentration of gold nanorod probes is approximately 109 per cubic centimeter or 1  g/kg. 
Even  though  the  concentration  of  nontoxic  probes  is  low,  the  procedure  will  need  to  be 
experimentally validated in terms of safety. 
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Fig.  6.  Sensitivity  of  gold  nanorod  labels  vs.  available  fluorescence  molecular  labels  and 
quantum  dots.  (a)  Concentration  of  labels  (per  mm
3)  needed  to  achieve  S/N  =  10.  The 
concentration of gold nanorod label (red curves) is three orders of magnitude lower than that of 
NIR1  fluorescence  dye  (green  curve)  and  CdTe/CdS  quantum  dot  (blue  curve).  (b) 
Detectability  of  several  common  fluorescent  molecular  and  quantum  dot  labels  and  gold 
nanorod labels (concentration of probes is 1 nM). Gold nanorod labels (red curves) provide 
more than two orders of magnitude increase in S/N over NIR1 and DDI fluorescence dyes 
(green curves) and CdTe/CdS quantum dot (blue curve). 
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tissue thickness. Here (Fig. 6b) gold nanorod labels (red curves) provide more than two orders 
of  magnitude  increase  in  S/N  over  NIR1  and  DDI  fluorescence  dyes  (green  curves)  and 
CdTe/CdS quantum dot (blue curve) for the same generic detector. More importantly gold 
nanorod labels can be employed at depths as great as 5 cm and still retain a S/N ratio of 10 
which is approximately a factor of two deeper than fluorescent labels. 
5. Discussion and conclusion 
We  see  that  nanorod  scattering  labels  can  achieve  two  to  three  orders  of  magnitude 
improvement in detectability compared to fluorescence labels, because of their extremely high 
plasmon resonant scattering. What is even more important, this improvement enables nanorod 
scattering probes to be detected in deep tissues where fluorescence probes perform poorly. 
Furthermore, nanorod labels can be tuned to any particular color simply by changing the 
aspect ratio, and thus could be used to image multiple molecular targets simultaneously. In the 
examples in the previous section the separation between two sets of nanorods is 80 nm which 
is several times the width of the plasmon resonance line. 
It is important to emphasize that in scattering cross-section measurements, the contribution 
of the 520 nm transverse plasmon mode is significantly lower than in absorption cross-section 
measurements. Thus, biomedical markers based on scattering would have a better line shape 
by reducing the background signals and possible interference from the transverse peak. 
Gold nanorod probes have several properties that make them especially suitable for in vivo 
application:  because  of  their  small  size  (approximately  100  times  smaller  volume  than 
available quantum dots) nanorod labels can be delivered to various tissues in the human body 
via  the  vasculature  and  microvasculature;  they  are  not  toxic;  they  can  be  tuned  for  near-
infrared detection wavelengths, which can propagate through several centimeters of tissue; 
finally, because of their extreme brightness, they potentially can achieve imaging sensitivity 
needed for single-cell detection in human organs. 
Overall, gold nanorod light scattering labels with a single, well defined aspect ratio might 
provide important advantages over fluorescent probes for biomedical imaging. 
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